Ohcanbohtosat - Anita K. Wagner
- Čájehuvvo 1 - 9 / 9
-
1
30 years of media coverage on high drug prices in the US - a never-ending story or a time for change? Dahkki Christine Leopold, James D Chambers, Anita K Wagner
Almmustuhtton 2015Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
2
Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand Dahkki Christine Leopold, Christine Y. Lu, Anita K. Wagner
Almmustuhtton 2020Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
3
Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway Dahkki Mahnum Shahzad, Huseyin Naci, Katharine M. Esselen, Joseph A. Dottino, Anita K. Wagner
Almmustuhtton 2024Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
4
1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities Dahkki Birna Trap, Moses N. Sembatya, Monica Imi, Morries Seru, Anita K. Wagner, Dennis Ross-Degnan
Almmustuhtton 2020Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
5
The Brazilian private pharmaceutical market after the first ten years of the generics law Dahkki Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens, Dennis Ross-Degnan
Almmustuhtton 2019Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
6
Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020Research in context Dahkki Yuxuan Wei, Yichen Zhang, Ziyue Xu, Guoan Wang, Yue Zhou, Huangqianyu Li, Luwen Shi, Huseyin Naci, Anita K. Wagner, Xiaodong Guan
Almmustuhtton 2024Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
7
Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context Dahkki Adriana M. Ivama-Brummell, Fernanda L. Marciniuk, Anita K. Wagner, Claudia G.S. Osorio-, Sabine Vogler, Elias Mossialos, Carla L. Tavares-, Huseyin Naci
Almmustuhtton 2023Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
8
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries Dahkki Christine Leopold, Aukje K Mantel-Teeuwisse, Sabine Vogler, Silvia Valkova, Kees de Joncheere, Hubert GM Leufkens, Anita K Wagner, Dennis Ross-Degnan, Richard Laing
Almmustuhtton 2014Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
9
Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China Dahkki Dr. Yu Fang, PhD, Anita K Wagner, DrPH, Shimin Yang, BS, Minghuan Jiang, MS, Fang Zhang, PhD, Dennis Ross-Degnan, ScD
Almmustuhtton 2013Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji